Journal of clinical oncology (JCO) |
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer |
nov. 15 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2. |
Jan. 19 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study-XELAVIRI (AIO KRK0110). |
Jan. 19 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database. |
mai. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma. |
mar. 18 |
4 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of clinical oncology (JCO) |
Popstantot |
mai. 18 |
5 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis. |
mai. 19 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer. |
oct. 18 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Associations of Pre- and Postdiagnosis Diet Quality With Risk of Mortality Among Men and Women With Colorectal Cancer |
oct. 18 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial. |
juil. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer. |
mar. 18 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial. |
sep. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial. |
sep. 18 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9). |
mar. 18 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone |
juin. 16 |
3 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of clinical oncology (JCO) |
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer. |
oct. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial. |
sep. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma. |
Jan. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study |
juil. 16 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study. |
fév. 18 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial |
aoû. 16 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of Hepatology |
Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma |
aoû. 16 |
1 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of Hepatology |
Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis |
nov. 15 |
2 ♥ |
Foie |
Journal of Hepatology |
Extensive testing or focused testing of patients with elevated liver enzymes. |
fév. 17 |
4 ♥ |
Foie |
Journal of Hepatology |
Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis |
sep. 16 |
1 ♥ |
Hépatites virales, Foie |